Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids—Cannabinoids and Acute Stress Modulate GABA Release
Authors:
Open Access
- 12 July 2011
- journal article
- research article
- Published by Hindawi Limited in International Journal of Cell Biology
- Vol. 2011, 1-10
Abstract
We studied the effects of cannabinoids and acute immobilization stress on the regulation of GABA release in the olfactory bulb. Glutamate-stimulated 3H-GABA release was measured in superfused slices. We report that cannabinoids as WIN55, 212-2, methanandamide, and 2-arachidonoylglycerol were able to inhibit glutamate- and KCl-stimulated 3H-GABA release. This effect was blocked by the CB1 antagonist AM281. On the other hand, acute stress was ableper seto increase endocannabinoid activity. This effect was evident since the inhibition of stimulated GABA release by acute stress was reversed with AM281 and tetrahydrolipstatin. Inhibition of the endocannabinoid transport or its catabolism showed reduction of GABA release, antagonized by AM281 in control and stressed animals. These results point to endocannabinoids as inhibitory modulators of GABA release in the olfactory bulb acting through an autocrine mechanism. Apparently, stress increases the endocannabinoid system, modulating GABAergic synaptic function in a primary sensory organ.Keywords
This publication has 63 references indexed in Scilit:
- Rodent model of infant attachment learning and stressDevelopmental Psychobiology, 2010
- Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significanceImmunobiology, 2010
- Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding ProteinsChemistry & Biology, 2009
- Cannabinoid action in the olfactory epitheliumProceedings of the National Academy of Sciences, 2007
- Erratum to “The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH” [Pharmacol. Res. 54 (2006) 481–485]Pharmacological Research, 2007
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- Cannabinoid receptors and endocannabinoids: Evidence for new playersThe AAPS Journal, 2006
- Cannabinoid signallingLife Sciences, 2006
- Rimonabant: The first therapeutically relevant cannabinoid antagonistLife Sciences, 2005
- Inverse agonism and neutral antagonism at cannabinoid CB1 receptorsLife Sciences, 2005